Editorials

• Current Indications for Percutaneous Closure of Patent Foramen Ovale

  Marco Hernández-Enríquez, Xavier Freixa

  Rev Esp Cardiol. 2014;67:603-7

• What Cardiologists Should Know About Copeptin

  Maria Rubini Gimenez, Karin Wildi, Christian Mueller

  Rev Esp Cardiol. 2014;67:519-21

• Substrate Ablation of Post-infarction Ventricular Tachycardias

  Pablo Ávila, Ángel Arenal

  Rev Esp Cardiol. 2014;67:514-8

• Nitric-oxide Coated Bioactive Titanium Stents: Safer and More Effective Than Second-generation Drug-eluting Stents?

  Manel Sabaté, Salvatore Brugaletta

  Rev Esp Cardiol. 2014;67:511-3

• Epicardial Fat, Metabolic Dysregulation, and Cardiovascular Risk: Putting Things Together

  Francisco López-Jiménez, Ondrej Sochor

  Rev Esp Cardiol. 2014;67:425-7

• Basis for the Interpretation of Noninferiority Studies: Considering the ROCKET–AF, RE-LY, and ARISTOTLE Studies

  Ignacio Ferreira-González

  Rev Esp Cardiol. 2014;67:432-5

• Decision Making Between Percutaneous Coronary Intervention or Bypass Surgery in Multi-vessel Coronary Disease

  Gill Louise Buchanan, Gennaro Giustino, Alaide Chieffo

  Rev Esp Cardiol. 2014;67:428-31

• Management of Symptomatic Hypertrophic Cardiomyopathy: Pills, Alcohol, or the Scalpel?

  Bernard J. Gersh, Rick A. Nishimura

  Rev Esp Cardiol. 2014;67:341-4

• Laws Restricting Smoking in Public Places Reduce the Incidence of Acute Coronary Syndrome in Spain

  Jaime Fernández de Bobadilla, Regina Dalmau, Enrique Galve, on behalf of the “Legislation on Tobacco and Acute Coronary Syndrome in Spain” group

  Rev Esp Cardiol. 2014;67:349-52

• Treatment of Recurrent Pericarditis

  Massimo Imazio

  Rev Esp Cardiol. 2014;67:345-8

• Improving Knowledge of Arterial Resistant Hypertension: What Is Relevant?

  Josep Redon

  Rev Esp Cardiol. 2014;67:251-3

• Cooperative Research in Biomedicine. Spain's Cardiovascular Network, Red de Investigación Cardiovascular

  David García-Dorado García, Javier Díez, Juan Cinca, Jaume Marrugat, Francisco Fernández-Avilés Díaz

  Rev Esp Cardiol. 2014;67:254-8

• First, Let's See Where We Stand. Then, Let's See How Far We Can or Want to Go

  Julián Pérez-Villacastín

  Rev Esp Cardiol. 2014;67:249-50

• Triple Antithrombotic Therapy: Risky but Sometimes Necessary

  Rikke Sørensen, Gunnar Gislason

  Rev Esp Cardiol. 2014;67:171-5

• Brugada Syndrome and Pregnancy: Delving Into the Role of Sex Hormones in Ion Channelopathies

  Begoña Benito, Antonio Berruezo

  Rev Esp Cardiol. 2014;67:165-7

• Is It Possible to Train Non-cardiologists to Perform Echocardiography?

  Miguel Angel Garcia Fernandez

  Rev Esp Cardiol. 2014;67:168-70

• Comments on the 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease

  Working Group of the SEC on the 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease, reviewers for the 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease, and SEC Guidelines Committee

  Rev Esp Cardiol. 2014;67:80-6

• Cardiovascular Risk Functions: Usefulness and Limitations

  Roberto Elosua

  Rev Esp Cardiol. 2014;67:77-9

• Comments on the ESC Guidelines on Diabetes, Prediabetes, and Cardiovascular Diseases Developed in Collaboration with the European Society for the Study of Diabetes

  Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease, Expert Reviewers for the ESC Guidelines on Diabetes, Prediabetes And Cardiovascular Disease, Guideliness Committee of the SEC

  Rev Esp Cardiol. 2014;67:87-93

• Platelet Function and Hyperglycemia in Acute Coronary Syndrome

  Manel Puig Domingo

  Rev Esp Cardiol. 2014;67:3-5